Related Experiment Video
Updated: Jun 10, 2026

09:45
Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
Published on: November 14, 2025
Circulating Tumor Cell Enrichment and Single-Cell Isolation Combining the CellSearch® and DEPArray™ Systems
Cäcilia Köstler1, Bernhard Polzer2, Barbara Alberter2
1Cellular and Molecular Diagnostics Group, Division of Personalized Cancer Therapy, Fraunhofer Institute of Toxicology and Experimental Medicine ITEM-R, Regensburg, Germany. caecilia.koestler@item.fraunhofer.de.
Methods in Molecular Biology (Clifton, N.J.)
|January 9, 2024
Summary
Circulating tumor cells (CTCs) analysis via liquid biopsy offers a minimally invasive method for cancer detection and monitoring. This workflow enhances CTC isolation for detailed molecular analysis, aiding cancer research and therapy.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Circulating tumor cells (CTCs) are crucial biomarkers for cancer detection, prognosis, and treatment monitoring.
- Liquid biopsy, using blood draws, provides a less invasive alternative to tissue biopsies for accessing CTCs.
- Understanding CTCs' molecular traits is key to deciphering metastatic progression and patient outcomes.
Purpose of the Study:
- To present a comprehensive workflow for CTC enrichment and single-cell isolation.
- To enable detailed molecular analysis of individual CTCs for cancer research.
- To improve the utility of liquid biopsies in oncology.
Main Methods:
- Utilized the FDA-cleared CellSearch® system for CTC enrichment.
- Employed DEPArray™ technology for precise isolation of single CTCs.
- Integrated these methods into a workflow for subsequent molecular single-cell analyses.
Main Results:
- The described workflow effectively enriches CTCs from blood samples.
- Single CTCs can be reliably isolated using DEPArray™ technology post-enrichment.
- This enables downstream molecular characterization of individual CTCs.
Conclusions:
- The CellSearch® and DEPArray™ workflow provides a powerful tool for CTC analysis.
- This approach advances the potential of liquid biopsies in cancer diagnostics and therapeutics.
- Further molecular single-cell analyses of CTCs can yield critical insights into cancer biology.

